| View |
LRV2024-08-20-0385
|
BACILLUS CALMETTE-GUERIN (BCG) VACCINE
|
-
|
BR-596
|
202401a001
|
Packaging Lot (Box and Ampoule): 202401a001; (Diluent): 90230322-1
|
29-Aug-24
|
31-Dec-25
|
| View |
LRV2024-08-20-0387
|
PURIFIED CHICK EMBRYO CELL CULTURE RABIES VACCINE
|
VAXIRAB N
|
BRP-071
|
RV40031
|
Packaging Lot (Box and Vial): RV40031; (Diluent): CH323002
|
29-Aug-24
|
30-Apr-27
|
| View |
2023-05-09-0161
|
TRIVALENT SEASONAL INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED) 2023 SOUTHERN HEMISPHERE STRAIN
|
INFLUVAC
|
BR-901
|
F28A
|
Packaging Lot: (Box and Pre-filled Syringe): F28A
|
29-Feb-24
|
11 May 2023
|
| View |
LRV2024-09-25-0438
|
RABIES VACCINE (INACTIVATED)
|
CHIRORAB
|
BR-515
|
R24014A
|
Packaging Lot (Box and Vial): R24014A; (Diluent): S-273; (Needle): 3088011
|
29-Feb-28
|
01 October 2024
|
| View |
LRV2024-09-06-0409
|
JAPANESE ENCEPHALITIS VACCINE (LIVE, ATTENUATED)
|
IMOJEV
|
BR-923
|
08C2401-2
|
Packaging Lot (Box): 08C2401JB; (Vial): 08C2401-2; (Diluent): 14A2407-1; (Needle 25G X 5/8"): 2309064; (Needle 23G X 1"): 2306030; (Syringe 1 cc/mL): 231023D
|
29-Jan-28
|
12-Sep-24
|
| View |
2021-08-26-0449
|
BEVACIZUMAB
|
AVASTIN
|
BR-969
|
B7271
|
Packaging Lot (Box):B7271B01
|
3 June 2023
|
31 August 2021
|
| View |
2021-10-27-0512
|
HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)
|
GARDASIL
|
BR-603
|
1286938
|
Packaging Lot (Box & Vial): U028260
|
3 March 2024
|
29 October 2021
|
| View |
2022-04-20-0095
|
MEASLES, MUMPS AND RUBELLA VIRUS VACCINE, LIVE (WITH rHA)
|
M-M-R II
|
BR-877
|
1199856
|
Packaging Lot (Box, Vial & Diluent): W007277; (Needle 23G x 1"): 2109018; (Needle 25G x 1"): 2110020
|
3 March 2024
|
26 April 2022
|
| View |
2022-03-31-0075
|
CHOLERA VACCINE (INACTIVATED, ORAL)
|
EUVICHOL-PLUS
|
BR-1384
|
EP36-21021
|
Packaging Lot (Box & Tube): EP36-21021
|
3 November 2023
|
4 April 2022
|
| View |
2023-02-15-0067
|
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 15-VALENT (ADSORBED)
|
VAXNEUVANCE
|
BR-1425
|
1538845
|
Packaging Lot (Box and PFS): W040330; (Needle 23G x 1"): 2206019, 2205056; (Needle 25G x 1"): 2208027
|
3-Aug-24
|
22 February 2023
|
| View |
LRV2024-05-28-0214
|
TETANUS IMMUNE GLOBULIN HUMAN
|
SERO-TET
|
BR-456
|
080T23003
|
Packaging Lot (Box and Vial): 080T23003
|
3-Aug-26
|
31 May 2024
|
| View |
2023-06-23-0189
|
QUADRIVALENT SEASONAL INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) 2023 SOUTHERN HEMISPHERE STRAIN
|
FLUQUADRI
|
BR-1421
|
U7942
|
Packaging Lot: (Box and Vial): UK000AB
|
3-Feb-24
|
30 June 2023
|
| View |
LRV2023-10-02-0317
|
HUMAN NORMAL IMMUNOGLOBULIN
|
IV-GLOBULIN SN INJECTION
|
BR-897
|
353R23006
|
Packaging Lot: (Box and Vial): 353R23006
|
3-Jan-26
|
05 October 2023
|
| View |
LRV2023-10-09-0327
|
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
|
HEPABIG
|
BR-334
|
230H23001
|
Packaging Lot: (Box and Vial): 230H23001
|
3-Jul-25
|
12 October 2023
|
| View |
LRV2024-10-03-0448
|
HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)
|
GARDASIL
|
BR-602
|
1661294
|
Packaging Lot (Box and PFS): Y005091; (Needle 23G x 1"): 2305076
|
3-Jun-26
|
09 October 2024
|
| View |
2018-09-03-0190
|
Tetanus Toxoid
|
Bio-TT
|
BR-663
|
280618
|
Packaging Lot (box and vial): 0280618
|
30 April 2021
|
05 September 2018
|
| View |
2018-10-19-0240
|
Human Papillomavirus Vaccine Types 16 and 18 (Recombinant, AsO4 Adjuvant)
|
Cervarix
|
BR-616
|
AHPVA341A
|
Packaging lot (box & pfs) - AHPVA341AI; Needle - 1712015 (ED: 2022-12-31)
|
30 April 2021
|
23 October 2018
|
| View |
2018-11-20-0257
|
Inactivated Hepatitis A Vaccine
|
Havrix 1440
|
BR-338
|
AHAVB965B
|
Packaging Lot (box & vial): AHAVB965BH
|
30 April 2021
|
22 November 2018
|
| View |
2018-11-21-0259
|
Hepatitis B Vaccine (rDNA)
|
Hepliv
|
BR-502
|
51A18005A
|
Packaging lot: 51A18005A
|
30 April 2021
|
26 November 2018
|
| View |
2018-12-14-0300
|
Combined Hepatitis A & B Vaccine
|
Twinrix Adult
|
BR-404
|
AHABB393A
|
Packaging Lot: Box & PFS- AHABB393AL; Needle - 1701028 (ED: 2022-01-31)
|
30 April 2021
|
19 December 2018
|